Pharmaceuticals, Biotechnology and Life Sciences
N4 Pharma will test a Covid-19 DNA plasmid if Nuvec, a novel delivery system for cancer treatments and vaccines, can be used as a delivery system by potential collaboration partners developing Covid-19 DNA or RNA vaccines.
@n4pharma with MedImmune UK, has been studying the level of immune response Nuvec can deliver when combined with a target antigen in a study using messenger RNA (mRNA) and plasmid DNA (pDNA) encoded with the standard test antigen Ovalbumin (OVA).
N4 Pharma has recruited a former AstraZeneca senior research scientist to lead the Nuvec, its lead vaccine delivery program.
N4 Pharma provided latest research results for its Nuvec nanoparticles which it is developing as a delivery system for DNA and mRNA vaccines and therapeutics.